We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Denies Petitions for CBD Rulemaking, Says Products Need New Regulatory Framework
FDA Denies Petitions for CBD Rulemaking, Says Products Need New Regulatory Framework
FDA Principal Deputy Commissioner Janet Woodcock announced Thursday that, after careful review, a new regulatory pathway for cannabidiol (CBD) review is needed and the agency is denying three citizen petitions to allow marketing of CBD products as dietary supplements.